Whistleblower: Pfizer COVID-19 vaccine has serious violations in Texas trials
- EPA Announces First-Ever Regulation for “Forever Chemicals” in Drinking Water
- Kochi University pioneers outpatient bladder cancer treatment using semiconductor lasers
- ASPEN 2024: Nutritional Therapy Strategies for Cancer and Critically Ill Patients
- Which lung cancer patients can benefit from neoadjuvant immunotherapy?
- Heme Iron Absorption: Why Meat Matters for Women’s Iron Needs
- “Miracle Weight-loss Drug” Semaglutide Is Not Always Effective
Whistleblower: Pfizer COVID-19 vaccine has serious violations in Texas trials
- Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Whistleblower: Pfizer COVID-19 vaccine has serious violations in Texas trials.
On November 3, reported that the British Medical Journal (BMJ) quoted Brooke Jackson, the former regional director of Ventavia Research in the United States, as saying that in the fall of 2020, Ventavia will conduct a trial for Pfizer’s COVID-19 vaccine in Texas. There are serious violations in.
Pfizer’s COVID-19 vaccine.
The magazine wrote: “Jackson disclosed to the British Medical Journal that Ventavia had falsified data, informed in advance that trial participants would be given the real vaccine or a placebo, used inadequately trained vaccinators, and had a negative impact on Pfizer’s Phase 3 vaccine. Follow-up of adverse reactions reported during the main study period is slow.”
According to the magazine, after informing Ventavia of these issues several times, Jackson sent an e-mail complaint to the U.S. Food and Drug Administration (FDA). On the night of sending an email to the FDA, Jackson was fired by Ventavia.
Ventavia stated on its website that the company is the largest private clinical research company in Texas.
On December 11, 2020, the FDA approved an emergency use authorization application for Pfizer’s COVID-19 vaccine. In August of this year, after Pfizer’s vaccine was fully approved, the FDA released an inspection summary of the company’s key trials. The FDA inspected 9 of the 153 sites tested, but Ventavia was not among the 9 inspected sites.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
